These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1017163)

  • 1. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
    Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar JM; Nieto J; Sancho J; Rodicio JL
    Med Clin (Barc); 1984 Nov; 83(14):572-4. PubMed ID: 6513646
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol, renin and hypertension: a review.
    Laragh JH; Bühler FR
    Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic regulation of circadian rhythmicity of the renin-angiotensin-aldosterone system in five subtypes of essential hypertension.
    Cugini P; Manconi R; Mancini A; Serdoz R; Meucci T; Scavo D
    G Ital Cardiol; 1980; 10(2):184-90. PubMed ID: 6102942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The renin-angiotensin-aldosterone system in essential arterial hypertension].
    Ruilope L; Alcazar JM; García Robles R; Gutiérrez Millet V; Jarillo MD; Torres J; Morales JM; Rodicio JL
    Rev Clin Esp; 1977 Sep; 146(5):233-7. PubMed ID: 928859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
    Stumpe KO; Kolloch R; Gramann W; Vetter H; Krück F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1325-8. PubMed ID: 1029991
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of plasma renin activity in patients with hypertension.
    Kokot F; Kuska J; Czekala Z; Kiecoń I
    Pol Med J; 1968; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract]   [Full Text] [Related]  

  • 11. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions.
    Vaughan EF; Laragh JH
    Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)].
    Lardoux H; Vial FS; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1977 Sep; 6(30):2659-63. PubMed ID: 20602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of beta blockade on the renin-angiotensin-aldosterone system [proceedings].
    Lijnen PJ; Amery AK; Fagard RH
    Arch Int Physiol Biochim; 1979 Feb; 87(1):191-3. PubMed ID: 92268
    [No Abstract]   [Full Text] [Related]  

  • 16. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic ability of the renin-angiotensin-aldosterone-system (R.A.A.-system) stimulation as a screening test in hypertension].
    Schnurr E; Küppers H; Grabensee B
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():207. PubMed ID: 613574
    [No Abstract]   [Full Text] [Related]  

  • 18. [The renin-angiotensin-aldosterone system under stimulation conditions after kidney transplantation].
    Küppers H; Banzhaf R; Schnurr E
    Med Welt; 1981 Jul; 32(29):1141-2. PubMed ID: 7022102
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal profiling in the diagnosis and treatment of essential hypertension.
    Laragh JH
    Del Med J; 1974 Mar; 46(3):125-33. PubMed ID: 4361408
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.